Starbucks
SBUX
$101.68
+0.09%
Starbucks Corp is the world's largest and most recognizable coffee brand, operating a global network of nearly 41,000 company-operated and licensed cafes across over 80 countries, with its core business centered on premium beverages, food, and packaged goods. The company is a dominant market leader in the global coffeehouse industry, distinguished by its powerful brand, extensive physical footprint, and a highly customizable beverage platform. The current investor narrative is intensely focused on the company's operational turnaround strategy under CEO Brian Niccol, with recent news highlighting encouraging early signs of sales and profit growth, cost-cutting initiatives like corporate layoffs, and a significant stock rally as the market assesses the sustainability of this recovery momentum.…
SBUX
Starbucks
$101.68
Related headlines
Investment Opinion: Should I buy SBUX Today?
Rating & Thesis: SBUX is rated a Hold. The core thesis is that while the operational turnaround under CEO Brian Niccol shows encouraging early signs, the current valuation at a forward PE of 34.22x already prices in a significant earnings recovery, leaving an unfavorable risk/reward profile for new capital. This aligns with the neutral-to-cautious analyst sentiment, including RBC Capital's recent downgrade to 'Sector Perform'.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The stock trades at a premium forward PE of 34.22x vs. typical restaurant industry averages, 2) Revenue growth, while positive at 5.43% YoY, is not yet on a smooth, accelerating trajectory, 3) Profitability is severely challenged with a Q1 net income margin of just 2.96%, and 4) Despite the 69% implied upside to analyst targets, this requires perfect execution of a complex turnaround amidst financial strain (debt-to-equity of -3.29).
Risks & Conditions: The two biggest risks are persistent margin compression and a valuation de-rating. This Hold would upgrade to a Buy if the forward PE compresses below 25x without a deterioration in the growth outlook, or if Q2 results show gross margins recovering decisively above 20%. It would downgrade to a Sell if revenue growth decelerates below 3% or if the quarterly net income margin fails to show sequential improvement. The stock is currently overvalued relative to its near-term fundamentals and sector peers, but fairly valued if the full analyst EPS forecast of $5.08 is achieved.
Sign up to view all
SBUX 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock is in a transitional phase where promising turnaround momentum is counterbalanced by severe current profitability issues and a premium valuation. The base case (55% probability) of gradual improvement aligned with consensus estimates is most likely. The stance would upgrade to bullish on evidence of sustained margin recovery (gross margin >20% for two consecutive quarters) and downgrade to bearish on a breakdown below key technical support at $95, which would signal a failure of the recent rally. The high short ratio of 5.83 indicates significant skeptical positioning, which could fuel a sharp rally if the company beats expectations.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Starbucks's 12-month outlook, with a consensus price target around $132.18 and implied upside of +30.0% versus the current price.
Average Target
$132.18
11 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
11
covering this stock
Price Range
$81 - $132
Analyst target range
Analyst coverage is moderate with 11 firms providing estimates, and the institutional rating actions show a recent pattern of neutral to cautious optimism, with one notable downgrade from RBC Capital to 'Sector Perform' in March. The consensus sentiment leans bullish, with several firms maintaining 'Buy' or 'Overweight' ratings, and the average target price is implied by the estimated EPS of $5.08 and the forward PE of 34.22x, which calculates to approximately $173.80, representing a significant implied upside of about 69% from the current price of $103.04. The target range, derived from estimated EPS, spans from a low of $4.76 to a high of $5.35, translating to price targets of roughly $163 to $183 using the forward multiple; the high target assumes successful turnaround execution leading to multiple expansion and earnings at the top of the range, while the low target likely factors in ongoing margin pressures and execution risks. The wide spread between the low and high EPS estimates signals meaningful uncertainty among analysts regarding the pace and magnitude of the company's profit recovery.
Bulls vs Bears: SBUX Investment Factors
The investment debate for SBUX hinges on the tension between a promising operational turnaround narrative and stark current financial realities. The bull case, supported by a 69% implied analyst upside and strong cash flow, is currently stronger on forward-looking sentiment. However, the bear case presents formidable evidence with a 62% year-over-year profit decline and a valuation demanding flawless execution. The single most important factor is the resolution of severe margin compression; if gross margins can sustainably recover toward historical levels above 24%, the bull thesis will be validated. If they remain depressed, the high valuation multiple will prove unsustainable.
Bullish
- Strong Analyst Upside Implied: Analyst consensus implies a target price of approximately $173.80 based on a forward EPS of $5.08 and a forward PE of 34.22x. This represents a significant 69% upside from the current price of $103.04, reflecting strong institutional belief in the turnaround's success.
- Robust Free Cash Flow Generation: Despite profitability challenges, the company generated $1.27 billion in free cash flow in Q1 FY26 and $2.34 billion TTM. This strong cash generation funds strategic initiatives and supports the dividend, providing a financial cushion during the turnaround.
- Sustained Revenue Growth: Q1 FY26 revenue grew 5.43% year-over-year to $9.91 billion. This positive growth, coupled with a 20.73% six-month stock rally, indicates the market is rewarding early signs of operational recovery under the new strategy.
- Active Cost-Cutting Initiatives: Recent news confirms corporate layoffs of 300 employees as part of the turnaround strategy. These actions, alongside a forward PE (34.22x) significantly lower than the trailing PE (52.58x), signal management's focus on restoring profitability, which the market is pricing in.
Bearish
- Severe Margin Compression & Profit Collapse: Q1 FY26 net income plummeted 62% year-over-year to $293 million, and the quarterly gross margin collapsed to 15.63% from a TTM level of 24.15%. This acute profitability pressure directly challenges the valuation premium and turnaround narrative.
- Extremely High Valuation Multiples: The stock trades at a trailing PE of 52.58x and a forward PE of 34.22x, both at a premium to typical restaurant industry averages. This leaves minimal room for error; any stumble in the earnings recovery could trigger severe multiple compression.
- Weak Balance Sheet & High Leverage: The balance sheet shows a negative debt-to-equity ratio of -3.29 and a weak current ratio of 0.72, indicating high financial leverage and potential liquidity constraints. This limits financial flexibility during a critical operational pivot.
- Recent Momentum Deceleration: The stock is down 2.75% over the past month, underperforming the S&P 500 by 2.67 percentage points, signaling a potential consolidation or profit-taking phase after a strong rally. This suggests near-term skepticism about the pace of improvement.
SBUX Technical Analysis
The stock is in a sustained uptrend over the past year, evidenced by a 9.25% one-year price change, but this masks significant volatility and a recent pullback from highs. Currently trading at $103.04, the price sits at approximately 80% of its 52-week range ($77.99 to $108.88), indicating it has retreated meaningfully from its peak but remains well above its lows, suggesting the longer-term uptrend is intact but facing near-term resistance. Recent momentum shows a clear deceleration and divergence from the longer-term trend; the stock is down 2.75% over the past month, contrasting sharply with its positive 3.92% three-month and 20.73% six-month performance, signaling a potential consolidation or profit-taking phase after the strong rally earlier in the year. Key technical support is anchored at the 52-week low of $77.99, while immediate resistance is at the 52-week high of $108.88; a decisive breakout above $108.88 would signal a resumption of the bullish trend, while a breakdown below the $78 level would call the recovery story into question. With a beta of 0.977, the stock exhibits market-like volatility, which is notable given its recent price swings and suggests its moves are more tied to company-specific turnaround news than broad market gyrations.
Beta
0.98
0.98x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$78-$109
Price range past year
Annual Return
+8.8%
Cumulative gain past year
| Period | SBUX Return | S&P 500 |
|---|---|---|
| 1m | -4.8% | +1.5% |
| 3m | +9.7% | +13.4% |
| 6m | +13.7% | +10.9% |
| 1y | +8.8% | +24.5% |
| ytd | +21.1% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SBUX Fundamental Analysis
Revenue growth is positive but has shown signs of deceleration and volatility on a quarterly basis; the most recent Q1 FY26 revenue was $9.91 billion, representing a 5.43% year-over-year increase, but this follows a sequential decline from the prior quarter's $9.57 billion and a peak of $9.46 billion in Q3 FY25, indicating growth is not yet on a smooth, accelerating trajectory. Profitability remains challenged with significant margin compression; net income for Q1 FY26 was $293 million, a sharp drop from $781 million in the year-ago quarter, and the gross margin of 15.63% in the latest quarter is severely depressed compared to the trailing twelve-month gross margin of 24.15%, highlighting acute cost pressures and investment spend related to the turnaround. The balance sheet shows financial strain with a negative debt-to-equity ratio of -3.29 and a weak current ratio of 0.72, indicating high leverage and potential liquidity constraints; however, the company continues to generate substantial operating cash flow ($1.60 billion in Q1) and free cash flow ($1.27 billion in Q1), providing internal funding for its strategic initiatives and supporting its dividend, which had a payout ratio of 149% based on trailing data.
Quarterly Revenue
$9.9B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.15%
Latest Quarter
Free Cash Flow
$2.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SBUX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is elevated at 52.58x, while the forward PE is lower at 34.22x; this significant gap implies the market is pricing in a substantial recovery in earnings over the next twelve months, aligning with the turnaround narrative. Compared to sector averages, Starbucks trades at a premium; its forward PE of 34.22x is above typical restaurant industry averages (often in the low-to-mid 20s), a premium that must be justified by a successful execution of its growth and margin restoration plan. Historically, the current trailing PE of 52.58x is near the top of its own range over the past several quarters, which have seen values fluctuate from the low 20s to over 180x during periods of extreme earnings volatility; trading near the high end of its historical band suggests investor optimism is already largely baked into the price, leaving little room for execution missteps.
PE
52.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~184x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Starbucks faces acute profitability risks, with Q1 FY26 net income collapsing to $293 million from $781 million a year ago, representing a 62% decline. The gross margin compression from a TTM 24.15% to a Q1 level of 15.63% highlights severe cost pressures and investment spend that could derail the turnaround if not quickly contained. Furthermore, the balance sheet is strained with a negative debt-to-equity ratio of -3.29 and a current ratio of 0.72, indicating high leverage and limited liquidity headroom, which could constrain strategic agility.
Market & Competitive Risks: The primary market risk is valuation compression. Trading at a forward PE of 34.22x, SBUX commands a significant premium to the restaurant sector, making it vulnerable to a de-rating if earnings growth disappoints. With a beta of 0.977, the stock exhibits market-like volatility, but its recent underperformance (down 2.75% in the past month vs. SPY's -0.08%) suggests it is sensitive to company-specific execution news. Competitive and macro risks include sustained consumer trade-down pressure and rising labor costs, which could further pressure the premium pricing model essential for margin recovery.
Worst-Case Scenario: The worst-case scenario involves a failure of the turnaround strategy, leading to continued margin erosion and a miss on the forward EPS estimate of $5.08. This would trigger analyst downgrades and a severe compression of the forward PE multiple toward the sector average (low 20s). Combined with a loss of investor confidence, the stock could re-test its 52-week low of $77.99. From the current price of $103.04, this represents a realistic downside of approximately -24%. A breach of this level could see further declines given the weak balance sheet.
FAQ
The key risks are, in order of severity: 1) Financial Risk: Severe margin compression (gross margin fell from 24.15% TTM to 15.63% in Q1) and a weak balance sheet (debt-to-equity -3.29) threaten profitability and flexibility. 2) Valuation Risk: The high forward PE of 34.22x makes the stock vulnerable to a sharp de-rating if earnings disappoint. 3) Execution Risk: The entire investment thesis depends on a successful operational turnaround; any misstep could reverse the recent 20.73% six-month rally. 4) Market Risk: With a beta of 0.977, the stock is not a defensive shelter during broader market downturns.
The 12-month forecast presents three scenarios. The Base Case (55% probability) targets $163-$173, assuming earnings meet the $5.08 consensus and the current forward PE holds. The Bull Case (25% probability) targets $173-$183 on flawless execution and multiple expansion. The Bear Case (20% probability) sees a drop to $78-$100 if the turnaround fails, triggering valuation compression. The most likely outcome is the Base Case, predicated on the assumption that management's cost initiatives gradually restore margins without a major stumble in sales growth.
SBUX is overvalued relative to its current fundamentals but may be fairly valued if future earnings materialize as forecast. The trailing PE of 52.58x is extremely high, reflecting depressed earnings. The forward PE of 34.22x is a premium to the restaurant sector, implying the market is paying for a significant profit recovery. Compared to its own 52-week range, trading at $103.04 (80% of the range) suggests the market has priced in much of the near-term optimism. The valuation implies the market expects a near-doubling of EPS to $5.08, leaving little margin for error.
SBUX is not a compelling buy at current levels for most investors. While analyst targets imply 69% upside, this requires a successful execution of a complex turnaround amidst severe margin pressure (Q1 gross margin 15.63%) and a high valuation (forward PE 34.22x). It could be a good buy for very patient, long-term investors with high conviction in management's strategy, but only on a significant pullback toward the $95 support level. The unfavorable risk/reward at the current price supports a Hold rating.
SBUX is unsuitable for short-term trading due to its high volatility (beta 0.977), turnaround-related uncertainty, and recent momentum deceleration (-2.75% past month). It is a candidate for a long-term investment horizon of 3-5 years for investors who believe in the durability of the brand and the new management's multi-year strategic plan. The 2.84% dividend yield provides some income, but the high payout ratio (149%) makes it less reliable for pure income seekers. A minimum holding period of 18-24 months is suggested to assess the turnaround's success beyond initial quarterly noise.
